A young woman who lost her sight cannot get funding for a specialist college for the blind.
Category Archives: Body Optimization
Bacteria dislodged by hospital decontamination work
Decontamination work after a bug outbreak at a hospital dislodged more bacteria, new papers show.
Estrogen’s opposing effects on mammary tumors in dogs
Dogs that are spayed at a young age have a reduced risk of developing mammary tumors, the canine equivalent of breast cancer. Early spaying reduces levels of estrogen production, leading many veterinarians and scientists to cast estrogen in a negative light when it comes to mammary cancer.
But the effects of estrogen on cancer risk in dogs aren’t straightforward, according to a new study led by researchers from Penn’s School of Veterinary Medicine. While it’s clear that spaying dogs greatly minimizes their risk of developing mammary cancer, the findings suggest that the practice may increase the risk of more aggressive cancers. And in spayed animals with mammary tumors, the team found that higher serum estrogen levels were actually protective, associated with longer times to metastasis and improved survival times.
“Dogs that remain intact and have their ovaries develop many more mammary tumors than dogs that were spayed, so removing that source of estrogen does have a protective effect,” says Karin U. Sorenmo, a veterinary oncologist at Penn Vet and senior author on the study, published in PLOS ONE. “Estrogen does seem to drive mammary cancer development. But what it does for progression to metastasis — that I think is more complicated.”
Sorenmo and colleagues have been studying mammary tumors in dogs as a way of improving care and treatment for pets but also to make insights into human breast cancer biology.
“Much of the research we do in veterinary medicine looks at what is done in people and then adapts it,” she says. “But dogs are such a great, comprehensive model for cancer. Yes, there are differences in biology between dogs and people, but here those differences may allow us to ask very probing questions about what estrogen is doing in both dogs with mammary cancer and women with breast cancer.”
The research used data from two prospective studies, including one involving dogs in the Penn Vet Shelter Canine Mammary Tumor Program, through which shelter dogs with mammary tumors receive treatment, are studied by researchers like Sorenmo, and then find foster or permanent homes.
The team evaluated 159 dogs with mammary cancer, 130 that were spayed as part of the study and 29 that remain intact. In addition to surgically removing the dogs’ measurable tumors, the team collected information on serum estrogen levels, tumor type, disease grade and stage, time to metastasis, and survival time.
Despite estrogen’s link with an increased risk of developing mammary tumors, the researchers found that higher serum estrogen levels also seemed to help dogs avoid some of the riskiest aspects of their disease. Unexpectedly, when dogs were spayed at the same time their tumors were removed, those with estrogen receptor-positive tumors that had higher serum estrogen took longer to develop metastatic disease and survived longer than dogs with lower estrogen levels, confirming that these tumors depended on estrogen for progression.
Sorenmo speculates that, in these cases, estrogen’s action may be nuanced. “It drives the cancer, but it also seems to control or modulate it, reining it in,” she says, because most dogs with high serum estrogen levels had lower-grade and estrogen receptor-positive tumors, rendering them susceptible to hormonal deprivation by spaying.
The protective role of estrogen was also surprisingly pronounced in dogs with estrogen-receptor negative mammary tumors. In these higher-risk cancers, high serum estrogen was associated with delayed or absent metastasis. Complementing these findings and supporting a potential broader, tumor receptor-independent anti-cancer effect driven by estrogen, dogs with low serum estrogen had a significantly increased risk for developing other non-mammary aggressive fatal tumors, such as hemangiosarcoma, during their follow-up after mammary tumor surgery.
Some of the findings contradict what has been found in women with breast cancer. For example, higher serum estrogen levels in women following breast cancer therapy have been associated with higher rates of recurrence. But Sorenmo also notes that many cases of breast cancer in women arise just after menopause, when estrogen levels tumble. So there may be a more complex role for estrogen in people’s cancer risk as well.
The work points to new possibilities for examining the role of estrogen in cancer initiation and progression. Already, Sorenmo and colleagues, including Penn Vet’s Susan Volk and Ellen Puré, are pursuing investigations of how the hormone affects the tumor microenvironment, cells that aren’t themselves cancerous but may either stem or encourage a tumor’s growth and spread.
“I think this study opens some really complicated questions,” Sorenmo says. “If we start dissecting exactly what estrogen is doing, what genes or immune cells it’s interacting with, maybe we could harness the power of estrogen to be more clever in our treatment strategies.”
Lymphatic system found to play key role in hair regeneration
Given the amount of wear and tear it’s subjected to on a daily basis, the skin has a phenomenal ability to replenish itself. Spread throughout it are small reservoirs of stem cells, nested within supportive microenvironments called niches, which keep a tight rein on this repair process. Too much tissue might cause problems like cancer, while too little might accelerate aging.
Until now, scientists were uncertain whether the stem cells themselves could instruct other stem cells to form new skin by reshaping their niche. But new research in Science, led by Elaine Fuchs, the Rebecca C. Lancefield Professor, indicates that stem cells can indeed influence tissue regeneration. The study identifies a molecular coordination tool used by stem cells to signal across niches.
The researchers also discovered a new component of the niche: a specialized type of vessel called lymphatic capillaries, which transport immune cells and drain excess fluids and toxins from tissues. These capillaries form an intimate network around the stem cell niche within each hair follicle, the study showed, thereby interconnecting all its niches.
“By turning the skin completely transparent,” says postdoctoral fellow Shiri Gur-Cohen, “we were able to reveal the complex architecture of this network of tubes.”
Hair-follicle stem cells control the behavior of lymphatic capillaries by secreting molecules that act as an on-off switch for drainage, the scientists found, enabling them to control the composition of fluids and cells in the surrounding locale and ultimately synchronize regeneration across the tissue.
“The involvement of the lymphatic system in this process is a new concept,” says Fuchs, “and might potentially provide new therapeutic targets for lymph-related conditions such as wound-healing defects and hair loss.”
Story Source:
Materials provided by Rockefeller University. Note: Content may be edited for style and length.
How the Aztecs could improve modern urban farming
Roland Ebel of the Sustainable Food Systems Program at Montana State University conducted a research project to determine the extent to which an ancient Aztec agricultural technique could benefit 21st century horticultural needs.
Specifically, Ebel examined the use of “chinampas” with the hope of discovering their modern utility. A chinampa is a raised field on a small artificial island on a freshwater lake (usually surrounded by canals and ditches), where vegetables can be produced year round. The irrigation needs of chinampas is low and the productivity extremely high. Chinampas provide fresh produce for a megacity such as Mexico City and are conceivable around many of today’s exploding urban areas.
Ebel’s findings are illustrated in the article “Chinampas: An Urban Farming Model of the Aztecs and a Potential Solution for Modern Megalopolis,” found open access in the online journal HortTechnology.
The chinampa system, commonly called floating gardens, is still practiced in certain suburban areas in Xochimilco, in the southern valley of Mexico City. These raised fields are constructed by digging the canals and mounding the displaced earth onto platforms. Similar historic raised field systems can be found in South America, Asia, Oceania, and parts of Africa.
In a chinampa, the canal water rises through capillary action to the plant roots, which reduces irrigation demand. Additionally, a considerable portion of the soil fertility is generated in the canal floors. Complex rotations allow up to seven harvests in a year. Chinampas also provide ecosystem services, particularly greenhouse gas sequestration and biodiversity. In addition, the recreational benefits are tremendous: today, chinampas generate even more money from tourism than by horticultural production.
Ebel discovered the chinampa to be one of the most intensive and prolific production systems ever developed, and it is highly sustainable. It can be kept in almost continuous cultivation, and the microclimate is favorable for many horticultural crops, including ornamentals, which play an increasingly important role in Xochimilco. Even small animals can be raised on chinampas.
During the Aztec period (1325-1521), the development of chinampas is linked to high regional population density and the growth of sizable local urban communities. The raised field agriculture provided pre-Columbian farmers with better drainage, soil aeration, moisture retention during the dry season, and higher and longer-term soil fertility than in conventional outdoor production.
“Today, many cities face very similar challenges as Mexico City did 700 years ag — a rapidly growing population, and less and less arable land available for food production. Highly intensive production systems with low resource demand are, therefore, a strategic goal of urban agriculture developers. Thus, while most strategists emphasize high-tech solutions such as complex vertical farms, I think it is worthwhile to learn from the achievements of our ancestors,” states Ebel.
Nevertheless, despite versatile efforts to revitalize and reinterpret chinampas, the raised-field production system today is mostly limited to small-scale research and development projects.
Ebel supports efforts for a revitalization of the chinampa system. “A restored use of chinampas would allow intensive production of fresh vegetables close to Mexico City, avoiding transport needs and avoiding negative consequences on produce quality and greenhouse gas emissions,” he states.
Furthermore, chinampas could provide a series of desirable ecosystem services, including water filtration, regulation of water levels, microclimate regulation, increased biodiversity, and carbon capture and storage. Ebel adds, “Wherever you have freshwater lakes near a big city, chinampa-like systems are conceivable — and this applies for many parts of the world.”
The benefits of creating chinampas are not limited to big cities, although the assistance it could provide urban farming would be difficult to overstate. This system could be adopted into smaller rural communities as well, especially in tropical wetlands.
Best of frenemies: Unexpected role of social networks in ecology
Social networking, even between competing species, plays a much bigger role in ecology than anyone previously thought, according to three biologists at the University of California, Davis.
“There’s mounting evidence that different species pay attention to each other in the wild, especially if they share predators,” said Mike Gil, postdoctoral researcher at UC Davis. “The theory of ecology has lagged behind.”
Gil and co-authors Marissa Basket, associate professor of environmental science and policy, and Sebastian Schreiber, professor of evolution and ecology, outline their new theory in a paper published in the November issue of the journal Ecology.
Gil wants to understand how populations interact with each other and change over time. Traditionally, ecologists have focused on competition between species for food and other resources.
“But we typically leave out the specifics of animal decision making and social behavior,” Gil said.
Ecological frenemies
For example, gazelle, wildebeest or zebra could cue in to the presence of a predator such as a lion by seeing other species react, using the “network” to keep themselves safe. The new model by Gil, Basket and Schreiber is the first to take this kind of short-term information sharing into account at the population level.
“It completely changes the long-term dynamics of the system,” Gil said.
The effects are especially strong at low population densities, he said. When population density is high, the models show, competition between species is a stronger influence. Sheer numbers may also crowd out social cues.
The new theory could clear up some existing puzzles in ecology. For example, how do competing species co-exist without one driving the other out? A bit of help through social interactions could help “frenemies” get along, Gil said.
Technology brings new insights
Advances in technology — including cheaper cameras and sensors, and the computing power to manage large amounts of data — have made it easier than ever to study short-lived interactions between species in the wild, Gil said.
“We can collect data now that we could only dream about a decade ago,” he said. “It’s an exciting time to be a biologist.”
Story Source:
Materials provided by University of California – Davis. Note: Content may be edited for style and length.
Fluorescent probes offer fuller view of drug delivery in cells
Selecting the most effective molecules for drug delivery is often a trial-and-error process, but Cornell engineers are providing some precision thanks to a technique that reveals the performance of those molecules inside living cells.
Drug delivery systems control the time and place therapeutics are released inside the body. An essential component of many drug delivery systems is the molecule that links an antibody — which seeks out a target such as cancer cells — to a drug designed to destroy the target. The linker must not only keep the drug tethered to the antibody as it travels to a targeted cell, it must properly release the drug inside the cell, in the right place at the right time.
Biomolecular engineers gather clues about linkers’ effectiveness by testing them in cell-free environments — model fluids that don’t contain all the complex interactions typically found in whole, living cells. They’re easier to study, but aren’t always as accurate, potentially leading to linker failure in subsequent testing.
A research team led by Chris Alabi, associate professor of chemical and biomolecular engineering, has developed a method that employs fluorescent probes to see and measure the rate at which linkers successfully release drugs in living cells. The research, “Responsive Antibody Conjugates Enable Quantitative Determination of Intracellular Bond Degradation Rate,” published Oct. 8 in the journal Cell Chemical Biology.
“Right now, pharmaceutical companies make a ton of linkers and then see which functions best for a particular application by having to test each one. It’s a shotgun approach,” Alabi said. “With our technique, they can now make an informed decision based on actual intracellular numbers, before they put the drug system together.”
The probes consist of two fluorescent dyes that render each other invisible when they’re tethered together with the antibody as part of the delivery system. When the linker breaks and untethers the dyes, they become visible using a microscope, signaling the drug has been released inside the cell.
These probes were developed in Alabi’s lab and offer engineers an accurate way to measure the rate at which a linker’s chemical bond breaks from the delivery system while inside the cell.
“Once we know what the timing is for different linker bonds and cell processes, then we can say, ‘OK, for drug A connected to antibody B, this is how long it will take, so if we want to treat disease C, we should use this linker,'” Alabi said.
To demonstrate the probe, Alabi and his team engineered an antibody construct with a disulfide linker known to work well within the HER2 protein, a highly valued target for breast cancer treatment. Once the delivery system reached the protein, the team was able to reliably measure intracellular processes, such as the kinetics and half-life of the disulfide linker.
“For the biomolecular engineers and companies that have a target in mind, we can … make the drug discovery process that much faster because we now know something about how long it’s going to take to release the drug,” said Alabi, who hopes to demonstrate the technique further through partnerships with pharmaceutical companies.
The probes can also be used by chemical biologists to learn more about intracellular processes, such as the specific agents responsible for cleaving linkers, Alabi said.
The work was supported by funds from Cornell and the Nancy and Peter Meinig Investigator Fellowship.
Story Source:
Materials provided by Cornell University. Original written by Syl Kacapyr. Note: Content may be edited for style and length.
Researchers engineer insulin-producing cells activated by light for diabetes
Tufts University researchers have transplanted engineered pancreatic beta cells into diabetic mice, then caused the cells to produce more than two to three times the typical level of insulin by exposing them to light. The light-switchable cells are designed to compensate for the lower insulin production or reduced insulin response found in diabetic individuals. The study published in ACS Synthetic Biology shows that glucose levels can be controlled in a mouse model of diabetes without pharmacological intervention.
Insulin is a hormone that plays a central role in precisely controlling levels of circulating glucose — the essential fuel used by cells -. Diabetes affects more than 30 million Americans according to the Centers for Disease Control and Prevention (CDC). In type II diabetes — the most common form of the disease — the cells of the body become inefficient at responding to insulin and as a consequence, glucose in circulation can become dangerously high (hyperglycemia) while the pancreas cannot produce enough insulin to compensate. In type I diabetes, the beta cells, which are the only cells in the body that produce insulin, are destroyed by the immune system resulting in complete lack of the hormone.
Current treatments include the administration of drugs that enhance the production of insulin by pancreatic beta cells, or direct injection of insulin to supplement the naturally produced supply. In both cases, regulation of blood glucose becomes a manual process, with drug or insulin intervention conducted after periodic readings of glucose levels, often leading to spikes and valleys that can have harmful long-term effects.
The researchers sought to develop a new way to amplify insulin production while maintaining the important real-time link between the release of insulin and concentration of glucose in the bloodstream. They accomplished this by taking advantage of ‘optogenetics’, an approach relying on proteins that change their activity on demand with light. Pancreatic beta cells were engineered with a gene that encodes a photoactivatable adenylate cyclase (PAC) enzyme. The PAC produces the molecule cyclic adenosine monophosphate (cAMP) when exposed to blue light, which in turn cranks up the glucose-stimulated production of insulin in the beta cell. Insulin production can increase two- to three-fold, but only when the blood glucose amount is high. At low levels of glucose, insulin production remains low. This avoids a common drawback of diabetes treatments which can overcompensate on insulin exposure and leave the patient with harmful or dangerously low blood sugar (hypoglycemia).
Researchers found that transplanting the engineered pancreatic beta cells under the skin of diabetic mice led to improved tolerance and regulation of glucose, reduced hyperglycemia, and higher levels of plasma insulin when subjected to illumination with blue light.
“It’s a backwards analogy, but we are actually using light to turn on and off a biological switch,” said Emmanuel Tzanakakis, professor of chemical and biological engineering at the School of Engineering at Tufts University and corresponding author of the study. “In this way, we can help in a diabetic context to better control and maintain appropriate levels of glucose without pharmacological intervention. The cells do the work of insulin production naturally and the regulatory circuits within them work the same; we just boost the amount of cAMP transiently in beta cells to get them to make more insulin only when it’s needed.”
The blue light simply flips the switch from normal to boost mode. Such optogenetic approaches utilizing light-activatable proteins for modulating the function of cells are being explored in many biological systems and have fueled efforts toward the development of a new genre of treatments.
“There are several advantages to using light to control treatment,” said Fan Zhang, graduate student in Tzanakakis’ lab at Tufts and first author of the study. “Obviously, the response is immediate; and despite the increased secretion of insulin, the amount of oxygen consumed by the cells does not change significantly as our study shows. Oxygen starvation is a common problem in studies involving transplanted pancreatic cells.”
Story Source:
Materials provided by Tufts University. Note: Content may be edited for style and length.
New printer creates extremely realistic colorful holograms
Researchers have developed a new printer that produces digital 3D holograms with an unprecedented level of detail and realistic color. The new printer could be used to make high-resolution color recreations of objects or scenes for museum displays, architectural models, fine art or advertisements that do not require glasses or special viewing aids.
“Our 15-year research project aimed to build a hologram printer with all the advantages of previous technologies while eliminating known drawbacks such as expensive lasers, slow printing speed, limited field of view and unsaturated colors,” said research team leader Yves Gentet from Ultimate Holography in France. “We accomplished this by creating the CHIMERA printer, which uses low-cost commercial lasers and high-speed printing to produce holograms with high-quality color that spans a large dynamic range.”
In The Optical Society (OSA) journal Applied Optics, the researchers describe the new printer, which creates holograms with wide fields of view and full parallax on a special photographic material they designed. Full parallax holograms reconstruct an object so that it is viewable in all directions, in this case with a field of view spanning 120 degrees.
The printer can create holograms from 3D computer generated models or from scans acquired with a dedicated scanner developed by the researchers. The high-quality holograms can even be used as masters to produce holographic copies.
Building a better printer
When developing the new hologram printer, the researchers carefully studied two previously developed holographic printer technologies to understand their advantages and drawbacks.
“The companies involved in developing the first two generations of printers eventually faced technical limitations and closed,” said Gentet. “Our small, self-funded group found that it was key to develop a highly sensitive photomaterial with a very fine grain rather than use a commercially available rigid material like previous systems.”
The CHIMERA printer uses red, green and blue low-power commercially available continuous wave lasers with shutters that adjust the exposure for each laser in a matter of milliseconds. The researchers also created a special anti-vibrating mechanical system to keep the holographic plate from moving during the recording.
Holograms are created by recording small holographic elements known as hogels, one after another using three spatial light modulators and a custom designed full-color optical printing head that enables the 120-degree parallax. After printing, the holograms are developed in chemical baths and sealed for protection.
The hogel size can be toggled between 250 and 500 microns and the printing rate adjusted from 1 to 50 hertz (Hz). For example, if a hogel size of 250 microns is used, the maximum printing speed is 50 Hz. At this speed it would take 11 hours to print a hologram measuring 30 by 40 centimeters, about half of the time it would take using previous systems based on pulsed lasers.
High brightness and clarity
The researchers used the new technology to print holograms that measured up to 60 by 80 centimeters showing various color objects including toys, a butterfly and a museum object.
“The new system offers a much wider field of view, higher resolution and noticeably better color rendition and dynamic range than previous systems,” said Gentet. “The full-color holographic material we developed provides improved brightness and clarity while the low-power, continuous wave lasers make the system easy to use.”
The researchers say that as technology improves, especially 3D software, it may be possible to expand their hologram printing approach to medical or other advanced applications.
Story Source:
Materials provided by The Optical Society. Note: Content may be edited for style and length.
Blood inquiry judge: ‘Many left in grinding hardship’
Equal financial support should be given to all those affected in the UK, the judge says.
